Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Victoria Falco"'
Autor:
María Victoria Falco, Gabriela Fabbiani, Cecilia Maciel, Spring Valdivia, Nathalia Vitureira, Raúl E. Russo
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 17 (2023)
The ependyma of the spinal cord is a latent stem cell niche that is reactivated by injury, generating new cells that migrate to the lesion site to limit the damage. The mechanisms by which ependymal cells are reactivated after injury remain poorly un
Externí odkaz:
https://doaj.org/article/5f042b52d01e40f3beb8c60b3000bd27
Autor:
Lindsey E. Roeker, Tatyana A. Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey, Andrew D. Zelenetz, Lorenzo Falchi, Jae H. Park, David J. Straus, Camila Pena Velasquez, Sonia Lebowitz, Yehudit Fox, Kristen Battiato, Carissa Laudati, Meghan C. Thompson, Elizabeth McCarthy, Sabrina Kdiry, Rosalba Martignetti, Teja Turpuseema, Michelle Purdom, Dana Paskalis, Hari P. Miskin, Peter Sportelli, Lori A. Leslie, Anthony R. Mato
Publikováno v:
Clinical Cancer Research. 28:3958-3964
Purpose: Ibrutinib has transformed the management of chronic lymphocytic leukemia (CLL), though its use is limited by toxicity and resistance. In this study, we utilized an “add on” approach for patients who had been treated with ibrutinib in the
Autor:
Victoria Falco, María, Fabbiani, Gabriela, Maciel, Cecilia, Valdivia, Spring, Vitureira, Nathalia, Russo, Raúl E.
Publikováno v:
Frontiers in Cellular Neuroscience; 2023, p1-11, 11p
Autor:
Anthony R. Mato, Lori A. Leslie, Peter Sportelli, Hari P. Miskin, Dana Paskalis, Michelle Purdom, Teja Turpuseema, Rosalba Martignetti, Sabrina Kdiry, Elizabeth McCarthy, Meghan C. Thompson, Carissa Laudati, Kristen Battiato, Yehudit Fox, Sonia Lebowitz, Camila Pena Velasquez, David J. Straus, Jae H. Park, Lorenzo Falchi, Andrew D. Zelenetz, Colleen Dorsey, Gail Panton, Victoria Falco, Jacob D. Soumerai, Tatyana A. Feldman, Lindsey E. Roeker
Supplementary Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c05b3ff2d51e9213b86e98036b3c6f
https://doi.org/10.1158/1078-0432.22487868
https://doi.org/10.1158/1078-0432.22487868
Autor:
Anthony R. Mato, Lori A. Leslie, Peter Sportelli, Hari P. Miskin, Dana Paskalis, Michelle Purdom, Teja Turpuseema, Rosalba Martignetti, Sabrina Kdiry, Elizabeth McCarthy, Meghan C. Thompson, Carissa Laudati, Kristen Battiato, Yehudit Fox, Sonia Lebowitz, Camila Pena Velasquez, David J. Straus, Jae H. Park, Lorenzo Falchi, Andrew D. Zelenetz, Colleen Dorsey, Gail Panton, Victoria Falco, Jacob D. Soumerai, Tatyana A. Feldman, Lindsey E. Roeker
Purpose:Ibrutinib has transformed the management of chronic lymphocytic leukemia (CLL), though its use is limited by toxicity and resistance. In this study, we utilized an “add on” approach for patients who had been treated with ibrutinib in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a26e24bc38e973d8f286db775058e90
https://doi.org/10.1158/1078-0432.c.6532596
https://doi.org/10.1158/1078-0432.c.6532596
Autor:
Gabriela Fabbiani, Raúl E. Russo, María Victoria Falco, Cecilia Reali, Jimena Fagetti, María Inés Rehermann, Adrián Valentin-Kahan
Publikováno v:
J Neurosci
The ependyma of the adult spinal cord is a latent stem cell niche that is reactivated by spinal cord injury contributing new cells to the glial scar. The cellular events taking place in the early stages of the reaction of the ependyma to injury remai
Autor:
Gabriela Fabbiani, Omar Trujillo-Cenóz, Cecilia Maciel, María Victoria Falco, Raúl E. Russo, María Inés Rehermann
Publikováno v:
Journal of neuroscience researchREFERENCES. 99(10)
The cytoskeleton of ependymal cells is fundamental to organize and maintain the normal architecture of the central canal (CC). However, little is known about the plasticity of cytoskeletal components after spinal cord injury. Here, we focus on the st
Autor:
Kristen E. Battiato, Hari P. Miskin, Gail Panton, Camila Pena-Velasquez, Yehudit Fox, Victoria Falco, Rosalba Martignetti, Sabrina Kdiry, Lori A. Leslie, Elizabeth L. McCarthy, Lindsey E. Roeker, Carissa Laudati, Andrew D. Zelenetz, Jae H. Park, Sonia Lebowitz, Anthony R. Mato, Meghan C. Thompson, Lorenzo Falchi, Peter Sportelli, Jake D. Soumerai, David J. Straus
Publikováno v:
Blood. 138:395-395
Background: While time-limited novel agent combinations have demonstrated high overall response rates and durable responses for patients with chronic lymphocytic leukemia (CLL), they also have high rates of adverse events and possibly overtreat many
Autor:
Jae H Park, Eric S. Winer, Scott F. Huntington, Gottfried von Keudell, Shreya Vemuri, Madhulika Shukla, Julie C Kinoshita, Victoria Falco, Steven D. Gore, Richard M. Stone, Omar Abdel-Wahab, Martin S. Tallman
Publikováno v:
Blood. 138:43-43
Background: We have previously reported >90% overall response rates of the BRAF inhibitor, vemurafenib, in patients (pts) with relapsed or refractory (R/R) hairy cell leukemia (HCL) (Tiacci and Park et al. NEJM 2015). However, complete response (CR)
Autor:
Victoria Falco, Stephen J. Schuster, Meghan C. Thompson, Allison Nelson, Allison C. Rosenthal, Rachel Stowe, Min Gui, Tim McKinlay, Andrea Sitlinger, Kaitlin Kennard, Danielle M. Brander, Lindsey E. Roeker, Shalin K. Kothari, Francine M. Foss, Han W. Tun, Celina J. Komari, Anthony R. Mato, Albert Kearney, Iris Isufi, Jose F. Leis, Amber B. Koehler, Scott F. Huntington, Wei He, Wei Ding
Publikováno v:
Blood. 136:21-22
Introduction: With a median overall survival (OS) measured in months, successful treatment of Richter's transformation (RT) of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) remains a major unmet medical need. While targe